profit from every ₹100 of sales.
₹0₹100
MedPlus Health Services
₹616.80-1.38% today
-23.7% in 1 year
1-year low ₹579.801-year high ₹954.65
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹33.73 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What MedPlus Health Services sold, what it kept, and what it did with the cash.
Sales went from ₹45.3 billion in 2023 to ₹68.9 billion in 2026, with ₹2.20 billion of profit last year.
SalesProfit
MedPlus Health Services vs. similar companies
MedPlus Health Services grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| MedPlus Health Services | 33.7× · Expensive | ||
 JD Health International | 20.5× · Fair price | ||
 Tsuruha Holdings | 26.6× · Fair price | ||
 MatsukiyoCocokara & | 20.1× · Fair price | ||
 Yifeng Pharmacy Chain | 18.4× · Fair price |
AI analysis
An AI analyst reads MedPlus Health Services's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 45,287 | 55,735 | 61,361 | 68,925 | |
| 9,710 | 11,819 | 14,954 | 18,079 | |
| 873 | 1,315 | 2,373 | 3,245 | |
| 3,122 | 3,941 | 5,357 | 6,787 | |
| 498 | 655 | 1,503 | 2,196 | |
| 4.17 | 5.45 | 12.52 | 18.29 | |
| 21.4% | 21.2% | 24.4% | 26.2% | |
| 1.9% | 2.4% | 3.9% | 4.7% | |
| 1.1% | 1.2% | 2.4% | 3.2% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 27,967 | 30,048 | 33,601 | 39,325 |
| Cash | 2,284 | 912 | 861 | 1,984 |
| Total debt | 8,999 | 10,096 | 11,198 | 14,244 |
| Total liabilities | 13,062 | 14,274 | 16,202 | 19,579 |
| 14,912 | 15,779 | 17,406 | 19,754 | |
| 120 | 120 | 120 | 120 | |
| 4.3% | 5.2% | 7.9% | 9.2% | |
| 3.3% | 4.1% | 8.6% | 11.1% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 904 | 1,437 | 5,404 | 4,956 | |
| 1,690 | 844 | 595 | 1,230 | |
| -786 | 593 | 4,810 | 3,726 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 221 | 141 | 69 | 30 |
Valuation
- 33.7×
- –
- 0.53
- 5.3×
- 1.1×
- 19.9×
- 12.7×
- 5.0%
- 3.0%
- –
Profitability
- 26.2%
- 4.7%
- 3.2%
- –
- 8.7%
- 6.3%
- –
- –
- –
- –
Growth
- +15.0%
- +63.7%
- –
- –
- +0.1%
Financial health
- 1.8×
- 0.72
- –
- 3.3×
- 3.00
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 35%of 952
Bottom 35%of 884
Bottom 37%of 601
Top 36%of 887
Top 22%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
48No pass
Philip Fisher
53No pass
Peter Lynch
84Pass
Joel Greenblatt
20No pass
Charlie Munger
29No pass
Terry Smith
40No pass
Questions about MedPlus Health Services
Is MedPlus Health Services a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the MedPlus Health Services AI analysis
What does MedPlus Health Services do?
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It is in Pharmaceutical Retailers, based in Hyderabad, India.
Is MedPlus Health Services stock halal?
Yes. MedPlus Health Services passes our halal screen: its business is permitted and its debt is 19% of its market value, under the 30% limit. How we check
How has MedPlus Health Services stock done over the past year?
Down 23.7% over the past twelve months, to ₹616.80. It traded between ₹579.80 and ₹954.65 and is 35.4% below its high.
Who are MedPlus Health Services's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with MedPlus Health Services's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.